The SERC economic analysis shows that the proposed rule is not likely to increase regulatory costs, including transactional costs, or to adversely impact economic growth, job creation, investment, business competitiveness, productivity, or innovation in excess of $1 million in the aggregate within 5 years after rule implementation. It estimates the number of pain-management clinics subject to the rule as well as the owners, affiliated persons, and physicians likely to be affected. The rule will not affect costs to the agency, other governmental entities, nor will it affect state or local revenues. Aside from the fee to register new clinics, there are no transactional costs. The rule affects small businesses, but not small counties or cities. Alternatives to the text were discussed and considered at the rule hearing held by the department.
The person to be contacted regarding the above notice is: Anthony Jusevitch, Executive Director,